Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
20,19 USD | +0,30 % | +3,64 % | -26,61 % |
15/04 | VERACYTE, INC. : Obtiene una recomendación de compra de Goldman Sachs | ZM |
26/02 | VERACYTE, INC. : Morgan Stanley mantiene una recomendación de venta | ZM |
Resumen de negocios
Número de empleados: 815
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostic Products and Biopharmaceutical Services
100,0
%
| 297 | 100,0 % | 361 | 100,0 % | +21,76 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
92,7
%
| 263 | 88,7 % | 335 | 92,7 % | +27,23 % |
International
7,3
%
| 34 | 11,3 % | 27 | 7,3 % | -21,08 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 19/07/21 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/22 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/10/23 |
Richard T. Kloos
CTO | Chief Tech/Sci/R&D Officer | - | 05/04/12 |
Shayla Gorman
IRC | Investor Relations Contact | - | 01/02/22 |
Tracy Morris
IRO | Public Communications Contact | - | - |
John Leite
PRN | Corporate Officer/Principal | - | 01/09/22 |
Annie McGuire
HRO | Human Resources Officer | 44 | 28/02/22 |
Robert Brainin
PRN | Corporate Officer/Principal | 53 | 08/07/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 01/02/08 |
Robert Epstein
CHM | Chairman | 69 | 12/01/15 |
Karin Eastham
BRD | Director/Board Member | 74 | 01/12/12 |
John Bishop
BRD | Director/Board Member | 79 | 01/12/14 |
Jens Holstein
BRD | Director/Board Member | 60 | 01/08/20 |
Marc Stapley
CEO | Chief Executive Officer | 54 | 01/06/21 |
Eliav Barr
BRD | Director/Board Member | - | 09/08/22 |
Muna Bhanji
BRD | Director/Board Member | 61 | 19/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 78 436 369 | 75 801 277 ( 96,64 %) | 0 | 96,64 % |
Información de la empresa
Veracyte, Inc.
6000 Shoreline Court Suite 300
94080, South San Francisco
+650 243 6300
http://www.veracyte.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-26,61 % | 1538,89 M | |
-18,16 % | 11,03 mil M | |
+58,43 % | 3497,9 M | |
-31,31 % | 2225,62 M | |
-14,31 % | 2155,57 M | |
+34,35 % | 1116,95 M | |
-3,28 % | 737 M | |
-22,75 % | 477 M | |
-40,20 % | 411 M | |
+17,30 % | 342 M |
- Bolsa de valores
- Acciones
- Acción VCYT
- Empresa Veracyte, Inc.